Non-invasive positive pressure ventilation during sleep at 3800 m: Relationship to acute mountain sickness and sleeping oxyhaemoglobin saturation
- PMID: 20051046
- PMCID: PMC4183457
- DOI: 10.1111/j.1440-1843.2009.01678.x
Non-invasive positive pressure ventilation during sleep at 3800 m: Relationship to acute mountain sickness and sleeping oxyhaemoglobin saturation
Abstract
Overnight oxyhaemoglobin desaturation is related to AMS. AMS can be debilitating and may require descent. Positive pressure ventilation during sleep at high altitude may prevent AMS and therefore be useful in people travelling to high altitude, who are known to suffer from AMS.
Background and objective: Ascent to high altitude results in hypobaric hypoxia and some individuals will develop acute mountain sickness (AMS), which has been shown to be associated with low oxyhaemoglobin saturation during sleep. Previous research has shown that positive end-expiratory pressure by use of expiratory valves in a face mask while awake results in a reduction in AMS symptoms and higher oxyhaemoglobin saturation. We aimed to determine whether positive pressure ventilation would prevent AMS by increasing oxygenation during sleep.
Methods: We compared sleeping oxyhaemoglobin saturation and the incidence and severity of AMS in seven subjects sleeping for two consecutive nights at 3800 m above sea level using either non-invasive positive pressure ventilation that delivered positive inspiratory and expiratory airway pressure via a face mask, or sleeping without assisted ventilation. The presence and severity of AMS were assessed by administration of the Lake Louise questionnaire.
Results: We found significant increases in the mean and minimum sleeping oxyhaemoglobin saturation and decreases in AMS symptoms in subjects who used positive pressure ventilation during sleep. Mean and minimum sleeping SaO2 was lower in subjects who developed AMS after the night spent without positive pressure ventilation.
Conclusions: The use of positive pressure ventilation during sleep at 3800 m significantly increased the sleeping oxygen saturation; we suggest that the marked reduction in symptoms of AMS is due to this higher sleeping SaO2. We agree with the findings from previous studies that the development of AMS is associated with a lower sleeping oxygen saturation.
Conflict of interest statement
I, Pamela Johnson, received support from the Faculty of Medicine at the University of Sydney to partially finance one of the three treks undertaken in Nepal. I have no financial interest in any aspect of the research undertaken and have no conflict of interest issues nor relationships with any organizations involved in this work.
I, Dan Popa, have no financial interest in any aspect of the research undertaken and have no conflict of interest issues nor relationships with any organizations involved in this work.
I, Kim Prisk, have no financial interest in any aspect of the research undertaken and have no conflict of interest issues nor relationships with any organization involved in this work.
I, Colin Sullivan, have no financial interest in any aspect of the research undertaken and have no conflict of interest issues nor relationships with any organization involved in this work.
I, Natalie Edwards, have no financial interest in any aspect of the research undertaken and have no conflict of interest issues nor relationships with any organizations involved in this work.
Comment in
-
The highs and lows of gas exchange during sleep.Respirology. 2010 Feb;15(2):191-3. doi: 10.1111/j.1440-1843.2009.01693.x. Respirology. 2010. PMID: 20199639 No abstract available.
Similar articles
-
Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID).High Alt Med Biol. 2015 Jun;16(2):154-61. doi: 10.1089/ham.2014.1110. Epub 2015 May 7. High Alt Med Biol. 2015. PMID: 25950723 Clinical Trial.
-
Effect of repeated normobaric hypoxia exposures during sleep on acute mountain sickness, exercise performance, and sleep during exposure to terrestrial altitude.Am J Physiol Regul Integr Comp Physiol. 2011 Feb;300(2):R428-36. doi: 10.1152/ajpregu.00633.2010. Epub 2010 Dec 1. Am J Physiol Regul Integr Comp Physiol. 2011. PMID: 21123763 Clinical Trial.
-
Impact of Sleeping Altitude on Symptoms of Acute Mountain Sickness on Mt. Fuji.High Alt Med Biol. 2018 Jun;19(2):193-200. doi: 10.1089/ham.2017.0106. Epub 2018 May 9. High Alt Med Biol. 2018. PMID: 29741971
-
Pulse oximetry for the prediction of acute mountain sickness: A systematic review.Exp Physiol. 2024 Dec;109(12):2057-2072. doi: 10.1113/EP091875. Epub 2024 Sep 25. Exp Physiol. 2024. PMID: 39323005 Free PMC article.
-
The Impact of Nocebo and Placebo Effects on Reported Incidence of Acute Mountain Sickness.High Alt Med Biol. 2022 Mar;23(1):8-17. doi: 10.1089/ham.2021.0078. Epub 2021 Dec 29. High Alt Med Biol. 2022. PMID: 34964659 Review.
Cited by
-
Common High Altitudes Illnesses a Primer for Healthcare Provider.Br J Med Med Res. 2015;7(12):1017-1025. doi: 10.9734/BJMMR/2015/17501. Epub 2015 Apr 17. Br J Med Med Res. 2015. PMID: 27057512 Free PMC article.
-
Continuous positive airway pressure treatment for acute mountain sickness at 4240 m in the Nepal Himalaya.High Alt Med Biol. 2013 Sep;14(3):230-3. doi: 10.1089/ham.2013.1015. High Alt Med Biol. 2013. PMID: 24067184 Free PMC article.
-
Closing the loop: autonomous intelligent control for hypoxia pre-acclimatization and high-altitude health management.Natl Sci Rev. 2025 Mar 8;12(5):nwaf071. doi: 10.1093/nsr/nwaf071. eCollection 2025 May. Natl Sci Rev. 2025. PMID: 40309344 Free PMC article. Review.
-
Acute Mountain Sickness Symptoms Depend on Normobaric versus Hypobaric Hypoxia.Biomed Res Int. 2016;2016:6245609. doi: 10.1155/2016/6245609. Epub 2016 Oct 25. Biomed Res Int. 2016. PMID: 27847819 Free PMC article.
-
Adaptive Servoventilation as Treatment for Central Sleep Apnea Due to High-Altitude Periodic Breathing in Nonacclimatized Healthy Individuals.High Alt Med Biol. 2018 Jun;19(2):178-184. doi: 10.1089/ham.2017.0147. Epub 2018 Mar 13. High Alt Med Biol. 2018. PMID: 29641294 Free PMC article. Clinical Trial.
References
-
- Bartsch P, Baumgartner RW, Waber U, Maggiorini M, Oelz O. Comparison of carbon-dioxide-Enriched, oxygen-enriched and normal air in treatment of acute mountain sickness. Lancet. 1990;336:772–75. - PubMed
-
- Bartsch P, Bailey DM, Berger MM, Knauth M, Baumgartner RW. Acute Mountain Sickness: Controversies and Advances. High Alt Med Biol. 2004;5:110–23. - PubMed
-
- Basnyat B, Gertsch JH, Johnson EW, Castro-Marin F, Inoue Y, Yeh C. Efficacy of Low Dose Acetazolamide (125mgs BID) for the Prophylaxis of Acute Mountain Sickness: A Prospective, Double-blind, Randomised, Placebo-controlled. Trial High Alt Med Biol. 2003;4:45–52. - PubMed
-
- Burgess KR, Johnson PL, Edwards N, Cooper J. Acute mountain sickness is associated with sleep desaturation at high altitude. Respirology. 2004;9:485–92. - PubMed
-
- Davis PR, Kippax J, Shaw GM, Murdoch DR, Goodhall JL. 13thInternational Hypoxia Symposium. Banff; Alberta, Canada: 1999. A novel continuous positive airway pressure (CPAP) device for use at high altitude (Abstract)
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources